• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用氨氯地平-阿托伐他汀单片复方制剂治疗高血压和高胆固醇血症时,时间是一个重要问题吗?

Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?

作者信息

Zeng Rui, Wang Mian, Zhang Li

机构信息

Department of Cardiovascular Diseases, West China Hospital, School of Clinical Medicine, Sichuan University, Chengdu, Sichuan, China (mainland).

出版信息

Med Sci Monit. 2016 Jul 26;22:2648-55. doi: 10.12659/msm.896843.

DOI:10.12659/msm.896843
PMID:27459306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4973800/
Abstract

BACKGROUND Is the timing of dosing for amlodipine and atorvastatin important with regard to therapeutic efficacy? To answer this question, we designed an outpatient, practice-based, case-control study lasting 8 weeks. MATERIAL AND METHODS Two hundred patients were divided into 2 groups: in Group I, patients were provided with a single pill containing amlodipine/atorvastatin (5/20 mg) to be taken each night at 10 pm, and in Group II, patients were taking amlodipine (5 mg) and atorvastatin (20 mg) each morning at 7 am. RESULTS Our results indicated no obvious difference in blood pressure control between the 2 groups. Taking amlodipine at night not only lowered blood pressure, but it also provided better control during the peak blood pressure in the morning. Hypercholesterolemia control in the 2 groups was also not significantly different, taking atorvastatin in the morning was as effective as dosing at night in patients with hypercholesterolemia. While the carotid IMT, hs-CRP, and LVMI were significantly lower after treatment, no differences were found between the 2 groups. Although no obvious difference was found in adverse drug reactions between the 2 groups, compliance was much better in the single-pill group than in patients taking the 2 medications separately. CONCLUSIONS In conclusion, single-pill amlodipine-atorvastatin taken at night can lower blood pressure and reduce the morning peak blood pressure levels the next day. Additionally, this dosing method could improve patient adherence to the therapy.

摘要

背景

氨氯地平和阿托伐他汀的给药时间对治疗效果有重要影响吗?为了回答这个问题,我们设计了一项为期8周的门诊、基于实践的病例对照研究。

材料与方法

200名患者被分为两组:第一组患者每晚10点服用一粒含氨氯地平/阿托伐他汀(5/20毫克)的单一药丸,第二组患者每天早上7点服用氨氯地平(5毫克)和阿托伐他汀(20毫克)。

结果

我们的结果表明两组之间血压控制无明显差异。晚上服用氨氯地平不仅能降低血压,还能在早晨血压峰值时提供更好的控制。两组高胆固醇血症的控制也无显著差异,早晨服用阿托伐他汀对高胆固醇血症患者的效果与晚上给药相同。虽然治疗后颈动脉内膜中层厚度、高敏C反应蛋白和左心室质量指数显著降低,但两组之间未发现差异。虽然两组药物不良反应无明显差异,但单药丸组的依从性比分别服用两种药物的患者好得多。

结论

总之,晚上服用氨氯地平-阿托伐他汀单一药丸可降低血压并降低次日早晨的血压峰值水平。此外,这种给药方法可提高患者对治疗的依从性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/86cd302a50bb/medscimonit-22-2648-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/b2d1fb3f0a15/medscimonit-22-2648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/26dc3f98663d/medscimonit-22-2648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/ad23c2c0dcf8/medscimonit-22-2648-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/86cd302a50bb/medscimonit-22-2648-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/b2d1fb3f0a15/medscimonit-22-2648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/26dc3f98663d/medscimonit-22-2648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/ad23c2c0dcf8/medscimonit-22-2648-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e32/4973800/86cd302a50bb/medscimonit-22-2648-g004.jpg

相似文献

1
Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?使用氨氯地平-阿托伐他汀单片复方制剂治疗高血压和高胆固醇血症时,时间是一个重要问题吗?
Med Sci Monit. 2016 Jul 26;22:2648-55. doi: 10.12659/msm.896843.
2
Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.在非裔美国人中使用氨氯地平/阿托伐他汀单片制剂改善血压和胆固醇目标的实现情况:CAPABLE试验
Mayo Clin Proc. 2008 Jan;83(1):35-45. doi: 10.4065/83.1.35.
3
Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.单一片剂降压/降脂方案是否能提高美国管理式医疗参保者的依从性?一项非随机、观察性、回顾性研究。
Am J Cardiovasc Drugs. 2010;10(3):193-202. doi: 10.2165/11530680-000000000-00000.
4
[One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].阿托伐他汀与氨氯地平固定剂量复方制剂对比阿托伐他汀治疗的一年持续性研究
Orv Hetil. 2016 Mar 13;157(11):425-9. doi: 10.1556/650.2016.30401.
5
International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.国际开放标签研究,以评估单片氨氯地平/阿托伐他汀在实现各国特定指南所推荐的血压和血脂目标方面的疗效和安全性:JEWEL计划。
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):472-80. doi: 10.1097/HJR.0b013e32832b63f5.
6
Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients.日本门诊患者中,将氨氯地平和阿托伐他汀的两种药物治疗转换为同等剂量的单片治疗的效果。
Acta Med Okayama. 2020 Apr;74(2):103-108. doi: 10.18926/AMO/58267.
7
Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia.固定剂量氨氯地平和强效阿托伐他汀联合治疗高血压合并高胆固醇血症患者的临床获益。
J Am Heart Assoc. 2024 May 7;13(9):e033780. doi: 10.1161/JAHA.123.033780. Epub 2024 Apr 30.
8
Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia.固定剂量复方制剂(阿托伐他汀和氨氯地平)治疗未控制的高血压和血脂异常的疗效。
J Ayub Med Coll Abbottabad. 2011 Jul-Sep;23(3):97-100.
9
Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.氨氯地平和阿托伐他汀对原发性高胆固醇血症高血压患者血压、左心室重构及C反应蛋白的协同作用。
Heart Vessels. 2008 Mar;23(2):91-5. doi: 10.1007/s00380-007-1008-7. Epub 2008 Apr 4.
10
Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).单片氨氯地平/阿托伐他汀有助于不同种族患者实现血压和血脂的推荐目标(双子座-AALA研究)。
J Hum Hypertens. 2009 Mar;23(3):196-210. doi: 10.1038/jhh.2008.114. Epub 2008 Sep 18.

引用本文的文献

1
Effect and mechanism of HMG-CoA reductase inhibitor on the improvement of elderly essential hypertension-induced vascular endothelial function impairment based on the JAK/STAT pathway.基于 JAK/STAT 通路的 HMG-CoA 还原酶抑制剂改善老年原发性高血压血管内皮功能障碍的作用及机制。
Diagn Pathol. 2023 Sep 28;18(1):108. doi: 10.1186/s13000-023-01393-x.
2
EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA.阿托伐他汀/氨氯地平单片复方制剂治疗高血压合并血脂异常患者的疗效与安全性
Acta Clin Croat. 2018 Sep;57(3):464-472. doi: 10.20471/acc.2018.57.03.09.
3

本文引用的文献

1
A novel management program for hypertension.一种新颖的高血压管理方案。
Cardiovasc Diagn Ther. 2015 Aug;5(4):316-22. doi: 10.3978/j.issn.2223-3652.2015.05.13.
2
The prognostic value of long-term visit-to-visit blood pressure variability on stroke in real-world practice: a dynamic cohort study in a large representative sample of Chinese hypertensive population.长期逐次就诊血压变异性对现实世界中卒中的预后价值:一项针对中国高血压人群大型代表性样本的动态队列研究
Int J Cardiol. 2014 Dec 20;177(3):995-1000. doi: 10.1016/j.ijcard.2014.09.149. Epub 2014 Oct 30.
3
[2010 Chinese guidelines for the management of hypertension].
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.
用于预防动脉粥样硬化性心血管疾病的固定剂量联合疗法。
Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD009868. doi: 10.1002/14651858.CD009868.pub3.
[2010年中国高血压防治指南]
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jul;39(7):579-615.
4
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.欧洲高血压管理指南重新评估:欧洲高血压学会特别工作组文件
J Hypertens. 2009 Nov;27(11):2121-58. doi: 10.1097/HJH.0b013e328333146d.
5
Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study).氨氯地平和血管紧张素受体阻滞剂对颈动脉壁内膜中层厚度的影响比较(AAA研究:动脉粥样硬化研究中的氨氯地平与血管紧张素受体阻滞剂对比)
Diabetes Res Clin Pract. 2009 Jan;83(1):50-3. doi: 10.1016/j.diabres.2008.10.014. Epub 2008 Dec 12.
6
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.氨氯地平-阿托伐他汀联合用药对正常胆固醇血症肥胖高血压患者炎症标志物及胰岛素敏感性的影响。
Eur J Clin Pharmacol. 2006 Oct;62(10):817-22. doi: 10.1007/s00228-006-0176-1. Epub 2006 Aug 2.
7
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.氨氯地平和阿托伐他汀联合应用于高血压合并血脂异常患者的疗效和安全性:AVALON试验结果
J Clin Hypertens (Greenwich). 2006 Aug;8(8):571-81; quiz 582-3. doi: 10.1111/j.1524-6175.2006.05636.x.
8
Effects of atorvastatin on inflammation and oxidative stress.阿托伐他汀对炎症和氧化应激的影响。
Heart Vessels. 2005 Jul;20(4):133-6. doi: 10.1007/s00380-005-0833-9.
9
Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia.短期他汀类药物治疗通过抗氧化和抗炎作用改善高胆固醇血症患者的动脉僵硬度。
Heart Vessels. 2005 Feb;20(1):8-12. doi: 10.1007/s00380-004-0793-5.
10
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.同型半胱氨酸与“高危”高血压患者血小板及内皮激活标志物的关系:盎格鲁-斯堪的纳维亚心脏结局试验的一项子研究
Int J Cardiol. 2004 Apr;94(2-3):293-300. doi: 10.1016/j.ijcard.2003.06.002.